One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent ...

Pfizer said Friday that a clinical trial of its first pill to treat Covid-19 shows it is highly effective. The drug called Paxlovid achieved an 89 per cent reduction in risk of hospitalisation or ...

Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer, replacing Mikael ...

Pfizer hopes to benefit from that hype as it works feverishly on a weight loss pill it believes could be one of the first to hit the market soon. While there are approved weight loss injectable ...

An appeal tribunal has upheld almost £70m in fines for two companies’ “illegal behaviour” that upped NHS spending on ...

Armed with impressive new data for its oral antiviral Paxlovid, Pfizer has filed for emergency use authorisation as a COVID-19 treatment in the US – and signed a deal to allow other ...

Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...

Pfizer Inc (PFE.N) said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up. Use of the pill, Paxlovid, ...

BridgeBio shares climbed by nearly 25% Monday on news its drug for a cardiac form of transthyretin amyloidosis was approved ...

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...